Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00030446
What this trial is testing

Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 50
Not applicableStudy completedNCT01471483
What this trial is testing

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Memorial Sloan Kettering Cancer Center 50
Not applicableLooking for participantsNCT06308510
What this trial is testing

Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer

Who this might be right for
Gastric Cancer
Erasmus Medical Center 63
Testing effectiveness (Phase 2)Study completedNCT00093496
What this trial is testing

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT05065021
What this trial is testing

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+2 more
University Health Network, Toronto 40
Early research (Phase 1)Study completedNCT00575952
What this trial is testing

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+8 more
Gynecologic Oncology Group 27
Testing effectiveness (Phase 2)Study completedNCT01709487
What this trial is testing

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Jules Bordet Institute 19
Testing effectiveness (Phase 2)Ended earlyNCT01972516
What this trial is testing

Tivozanib As Maintenance Therapy In GYN

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 4
Large-scale testing (Phase 3)UnknownNCT03693248
What this trial is testing

Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more
Seoul National University Hospital 298
Testing effectiveness (Phase 2)Study completedNCT00030706
What this trial is testing

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Montefiore Medical Center
Not applicableActive Not RecruitingNCT06451263
What this trial is testing

Nudge to Gynecologic Oncology

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)Looking for participantsNCT07795749
What this trial is testing

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Who this might be right for
Esophageal CarcinomaGastric Cancer (Diagnosis)Colorectal Adenocarcinoma+3 more
University of California, Irvine 55
Large-scale testing (Phase 3)Looking for participantsNCT07708753
What this trial is testing

SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-resistant Primary Peritoneal CancerPlatinum-resistant Fallopian Tube Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 460
Early research (Phase 1)Not Yet RecruitingNCT07454031
What this trial is testing

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Who this might be right for
Peritoneal (Metastatic) Cancer
Peking University 22
Early research (Phase 1)Active Not RecruitingNCT05802056
What this trial is testing

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Clinical Stage IV Gastric Cancer AJCC v8Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00388037
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+12 more
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT00101257
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00574951
What this trial is testing

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)Study completedNCT05041257
What this trial is testing

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
AbbVie 79
Next Page